Earnings results expected in 47 days
Summary
2CV trading today higher at €3.46, an increase of 0.58% from yesterday's close, completing a monthly increase of 1.17% or €0.04. Over the past 12 months, 2CV stock gained 34.11%.
2CV is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 29, 2025.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
Want to track 2CV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
2CV Chart
ConvaTec Group plc (2CV) FAQ
What is the stock price today?
The current price is €3.46.
On which exchange is it traded?
ConvaTec Group plc is listed on XFRA.
What is its stock symbol?
The ticker symbol is 2CV.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Jul 29, 2025.
Has ConvaTec Group plc ever had a stock split?
No, there has never been a stock split.
ConvaTec Group plc Profile
| Medical Instruments & Supplies Industry | Healthcare Sector | Mr. Karim Bitar CEO | XDUS Exchange | GB00BD3VFW73 ISIN |
| United Kingdom Country | 10,489 Employees | - Last Dividend | - Last Split | - IPO Date |
ConvaTec Group plc is a global medical products and technologies company, specializing in advanced wound care, ostomy care, continence & critical care, and infusion care. It serves healthcare professionals, patients, and customers in over 100 countries with innovative solutions aimed at improving patient outcomes and reducing the overall cost of healthcare. The company's products are used in hospitals, long-term care facilities, and homecare settings, where they play a crucial role in managing complex medical conditions. Noteworthy for its extensive R&D efforts, ConvaTec develops new healthcare technologies that address evolving patient needs and comfort. Significantly contributing to the medical supplies sector, ConvaTec Group plc is recognized for enhancing quality of life through its product offerings and service excellence. With a focus on sustainability and responsibility, the company continually seeks ways to minimize its environmental footprint while maintaining the highest standards of patient care and trust in the medical community.
Contact Information
Address: 20 Eastbourne Terrace
Phone: 44 11 8952 8100
Website: https://www.convatecgroup.com
2025 © Marketlog. All Rights Reserved.
